{
    "2021-10-17": [
        [
            {
                "time": "",
                "original_text": "益方生物科创板上会在即：核心产品商业化待成型 “大方”斥资8亿用于股权激励",
                "features": {
                    "keywords": [
                        "益方生物",
                        "科创板",
                        "上会",
                        "核心产品",
                        "商业化",
                        "股权激励"
                    ],
                    "sentiment_score": 0.6,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "生物医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            }
        ]
    ]
}